vTv Therapeutics Inc (NASDAQ:VTVT) Insider Trading Activity – Major Shareholder Bought 815,217 shares of Stock

ME Staff

6 years ago

Insider Trading Activity For vTv Therapeutics Inc (NASDAQ:VTVT)

Ronald O Perelman , Major Shareholder of vTv Therapeutics Inc (NASDAQ:VTVT) reportedly Bought 815,217 shares of the company’s stock at an average price of 1.84 for a total transaction amount of $1,499,999.28 SEC Form

Insider Trading History For vTv Therapeutics Inc (NASDAQ:VTVT)

On 9/22/2015 Ronald O Perelman, Major Shareholder, bought 24,000 with an average share price of $6.82 per share and the total transaction amounting to $163,680.00.

On 9/25/2015 Paul G Savas, Director, bought 5,000 with an average share price of $6.62 per share and the total transaction amounting to $33,100.00.

On 9/28/2015 Ronald O Perelman, Major Shareholder, bought 40,000 with an average share price of $6.04 per share and the total transaction amounting to $241,600.00.

On 10/2/2015 Ronald O Perelman, Major Shareholder, bought 30,000 with an average share price of $6.26 per share and the total transaction amounting to $187,800.00.

On 12/15/2015 Noel Joseph Spiegel, Director, bought 5,710 with an average share price of $6.20 per share and the total transaction amounting to $35,402.00.

On 12/18/2015 Ronald O Perelman, Major Shareholder, bought 15,000 with an average share price of $6.40 per share and the total transaction amounting to $96,000.00.

On 1/13/2016 Ronald O Perelman, Major Shareholder, bought 15,000 with an average share price of $6.41 per share and the total transaction amounting to $96,150.00.

Analyst Ratings History For vTv Therapeutics Inc (NASDAQ:VTVT)

On 8/4/2017 HC Wainwright Set Price Target of rating Buy with a price target of $13.00
On 11/8/2017 Citigroup Reiterated Rating add
On 12/21/2017 Canaccord Genuity Set Price Target of rating Buy with a price target of $15.00
On 4/10/2018 Stifel Nicolaus Downgraded rating Buy to Hold
On 4/10/2018 Piper Jaffray Companies Downgraded rating Overweight to Neutral with a price target of $4.00
On 4/10/2018 Seaport Global Securities Downgraded rating Buy to Neutral
On 4/10/2018 Northland Securities Downgraded rating Outperform to Market Perform with a price target of $28.00

Recent Trading Activity for vTv Therapeutics Inc (NASDAQ:VTVT)
Shares of vTv Therapeutics Inc closed the previous trading session at with shares trading hands.